H(2)O(2)-Inactivated Salmonella typhimurium RE88 Strain as a New Cancer Vaccine Carrier: Evaluation in a Mouse Model of Cancer

PURPOSE: This study aimed to describe a novel cancer vaccine developed using H(2)O(2)-inactivated Salmonella typhimurium RE88 [with deletions of AroA (the first enzyme in the aromatic amino acid biosynthesis pathway) and DNA adenine methylase] as the carrier. METHODS: The pVLT33 plasmid was used to...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, Yingzi, Bai, Tingting, Tian, Yaomei, Zhou, Bailing, Wang, Yuanda, Yang, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7815095/
https://www.ncbi.nlm.nih.gov/pubmed/33488068
http://dx.doi.org/10.2147/DDDT.S282660

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7815095/
https://www.ncbi.nlm.nih.gov/pubmed/33488068
http://dx.doi.org/10.2147/DDDT.S282660

Ejemplares similares